US Stock MarketDetailed Quotes

INCY Incyte

Watchlist
  • 70.420
  • +0.410+0.59%
Close Feb 14 16:00 ET
  • 69.000
  • -1.420-2.02%
Post 20:01 ET
13.63BMarket Cap469.47P/E (TTM)

Incyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Incyte Q4 2024 Earnings Date

Currency：USDFeb 10, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.15B
1.18B
+33.42M
Beat Est.
+13.02%
+16.32%
+2.92%
EPS
1.24
1.02
-0.22
Miss Est.
+39.04%
+14.61%
-17.58%
Analyst Rating
Buy

Feb 17, 2025

Incyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.157B--
--2025/Q1-- / 1.005B--
Feb 10, 20252024/Q41.179B / 1.145B--
Oct 29, 20242024/Q31.138B / 1.077B--
Jul 30, 20242024/Q21.044B / 1.015B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.157B--
--2025/Q1-- / 1.005B--
Feb 10, 20252024/Q41.179B / 1.145B--
Oct 29, 20242024/Q31.138B / 1.077B--
Jul 30, 20242024/Q21.044B / 1.015B--

Unlock Free Earnings Estimates

Incyte Earnings Reports

  • Incyte | 10-K: FY2024 Annual Report

    Feb 10 16:06 ET

  • Incyte | 8-K: Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial Guidance and Highlights 2025 R&D Milestones

    Feb 10 07:06 ET

  • Incyte | 10-Q: Q3 2024 Earnings Report

    Oct 29, 2024 16:05 ET

  • Incyte | 8-K: Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

    Oct 29, 2024 07:08 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +17.56%
    DexCom
    DXCM
    +5.92%
    Hutchmed (China)
    HCM
    +4.39%
    New Fortress Energy
    NFE
    +2.70%
    Enerpac Tool
    EPAC
    +1.85%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 17, 2025

    Buy

    • Buy

      40.00%

    • Hold

      53.33%

    • Sell

      6.67%

    Price Target

    No Data

    Investment Theme CAR-T Therapy
    CAR-T Therapy
    Intraday-1.13%